The effects of resveratrol on the glycemic profile in type 2 Diabetes mellitus
DOI:
https://doi.org/10.33448/rsd-v14i6.48978Keywords:
Diabetes, Resveratrol, Glycemic control.Abstract
Type 2 Diabetes mellitus is characterized by high blood glucose levels, which, in the long term, can progress to complications affecting important organs throughout the body. The cause of diabetes is multifactorial, but lifestyle habits such as a sedentary lifestyle and inadequate diet favor obesity and the emergence of chronic diseases such as diabetes. In addition to effective drug therapies to control the disease, new therapeutic strategies for controlling chronic hyperglycemia are being studied, such as resveratrol, a polyphenol found in plums, grapes and red fruits, and has anti-inflammatory, antioxidant and antidiabetic properties. The objective of the work was to evaluate the effects of resveratrol on the glycemic profile in type 2 diabetes mellitus. The literature review methodology was based on the selection of articles related to the topic, published in scientific databases such as PubMed and Web of Science between 2014 and 2024. Resveratrol supplementation showed promise in glycemic control in type 2 diabetics, reducing plasma glucose levels, HbA1c, in addition to improve insulin action.
Downloads
References
Ali Sangouni, A., Abdollahi, S., & Mozaffari-Khosravi, H. (2022). Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial. BMC cardiovascular disorders, 22(1), 212. https://doi.org/10.1186/s
-022-02637-2
Almarshad, M. I., Algonaiman, R., Alharbi, H. F., Almujaydil, M. S., & Barakat, H. (2022). Relationship between Ultra-Processed Food Consumption and Risk of Diabetes Mellitus: A Mini-Review. Nutrients, 14(12), 2366. https://doi.org/10.3390/nu14122366
Bashmakov, Y. K., Assaad-Khalil, S. H., Seif, M. A., Udumyan, R., Megallaa, M., Rohoma, K. H., Zeitoun, M., & Petyaev, I. M. (2014). Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients. ISRN Endocrinology, 2014, 1–8. https://doi.org/10.1155/2014/816307
Bo, S., Ponzo, V., Ciccone, G., Evangelista, A., Saba, F., Goitre, I., Procopio, M., Pagano, G., Cassader, M., & Gambino, R. (2016). Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial. Pharmacological Research, 111, 896–905. https://doi.org/10.1016/j.phrs.2016.08.010
Bruckner, F., Gruber, J. R., Ruf, A., Edwin Thanarajah, S., Reif, A., & Matura, S. (2024). Exploring the Link between Lifestyle, Inflammation, and Insulin Resistance through an Improved Healthy Living Index. Nutrients, 16(3), 388. https://doi.org/10.3390/nu16030388
Carvalho, G. B., Dias-Vasconcelos, N. L., Santos, R. K. F., Brandão-Lima, P. N., Da Silva, D. G., & Pires, L. V. (2019). Effect of different dietary patterns on glycemic control in individuals with type 2 diabetes mellitus: A systematic review. Critical Reviews in Food Science and Nutrition, 60(12), 1999 2010. https://doi.org/10.1080/10408398.2019.1624498
Colberg, S. R., Sigal, R. J., Yardley, J. E., Riddell, M. C., Dunstan, D. W., Dempsey, P. C., Horton, E. S., Castorino, K., & Tate, D. F. (2016). Physical Activity/Exercise and Diabetes: A position statement of the American Diabetes Association. Diabetes Care, 39(11), 2065–2079. https://doi.org/10.2337/dc16-1728
Crossetti, M. G. M. (2012). Revisión integradora de la investigación en enfermería el rigor científico que se le exige. Maria Da Graça Oliveira Crossetti. Rev. Gaúcha Enferm.33(2):8-9. 10)
Demir, S., Nawroth, P. P., Herzig, S., & Üstünel, B. E. (2021). Emerging targets in type 2 diabetes and diabetic complications. Advanced Science, 8(18). https://doi.org/10.1002/advs.202100275
Gal, A. M., Arhire, L. I., Gherasim, A., Graur, M., Nita, O., Dumitrascu, O., Soimaru, R. M., Popa, A. D., & Mihalache, L. (2024). Association between Diet Quality and Eating Behavior in Type 2 Diabetes Adults: A Cross-Sectional Study. Nutrients, 16(13), 2047. https://doi.org/10.3390/nu16132047
Gil, A. C. (2017). Como elaborar projetos de pesquisa. (6ed). Atlas.
Goh, K. P., Lee, H. Y., Lau, D. P., Supaat, W., Chan, Y. H., & Koh, A. F. Y. (2014). Effects of Resveratrol in Patients with Type 2 Diabetes Mellitus on Skeletal Muscle SIRT1 Expression and Energy Expenditure. International Journal of Sport Nutrition and Exercise Metabolism, 24(1), 2–13. https://doi.org/10.1123/ijsnem.2013-0045
Harreiter, J., & Roden, M. (2023). Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023). Wiener Klinische Wochenschrift, 135(S1), 7–17. https://doi.org/10.1007/s00508-022-02122-y
Hoseini, A., Namazi, G., Farrokhian, A., Reiner, Z., Aghadavod, E., Bahmani, F., & Asemi, Z. (2019). The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Food & Function, 10(9), 6042–6051. https://doi.org/10.1039/c9fo01075k
Huang, D., Shi, G., Jiang, Y., Yao, C., & Zhu, C. (2020). A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomedicine & Pharmacotherapy, 125, 109767. https://doi.org/10.1016/j.biopha.2019.109767
Kataria, R., & Khatkar, A. (2019). Resveratrol in Various Pockets: a review. Current Topics in Medicinal Chemistry, 19(2), 116–122. https://doi.org/10.2174/1568026619666190301173958
Khodabandehloo, H., Seyyedebrahimi, S., Esfahani, E. N., Razi, F., & Meshkani, R. (2018). Resveratrol supplementation decreases blood glucose without changing the circulating CD14 + CD16 + monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Nutrition Research, 54, 40–51. https://doi.org/10.1016/j.nutres.2018.03.015
Korsholm, A. S., Kjær, T. N., Ornstrup, M. J., & Pedersen, S. B. (2017). Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months Treatment. International Journal of Molecular Sciences, 18(3), 554. https://doi.org/10.3390/ijms18030554
Krause, M., & De Vito, G. (2023). Type 1 and Type 2 diabetes mellitus: commonalities, differences and the importance of exercise and nutrition. Nutrients, 15(19), 4279. https://doi.org/10.3390/nu15194279
Liu, Y., Deng, J., Zhao, T., Yang, X., Zhang, J., & Yang, H. (2024). Bioavailability and mechanisms of dietary polyphenols affected by non-thermal processing technology in fruits and vegetables. Current Research in Food Science, 8, 100715. https://doi.org/10.1016/j.crfs.2024.100715
Ma, N., & Zhang, Y. (2022). Effects of resveratrol therapy on glucose metabolism, insulin resistance, inflammation, and renal function in the elderly patients with type 2 diabetes mellitus: A randomized controlled clinical trial protocol. Medicine, 101(32), e30049. https://doi.org/10.1097/md.0000000000030049
Mahjabeen, W., Khan, D. A., & Mirza, S. A. (2022). Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial. Complementary Therapies in Medicine, 66, 102819. https://doi.org/10.1016/j.ctim.2022.102819
Minari, T. P., Manzano, C. F., Tácito, L. H. B., Yugar, L. B. T., Sedenho-Prado, L. G., De Azevedo Rubio, T., Pires, A. C., Vilela-Martin, J. F., Cosenso-Martin, L. N., Moreno, H., & Yugar-Toledo, J. C. (2024). The impact of a nutritional intervention on glycemic control and cardiovascular risk markers in type 2 diabetes. Nutrients, 16(9), 1378. https://doi.org/10.3390/nu16091378
Naja, K., Anwardeen, N., Malki, A. M., & Elrayess, M. A. (2024). Metformin increases 3-hydroxy medium chain fatty acids in patients with type 2 diabetes: a cross-sectional pharmacometabolomic study. Frontiers in Endocrinology, 15, 1-11. https://doi.org/10.3389/fendo.2024.1313597
Nauck, M. A., Wefers, J., & Meier, J. J. (2021). Treatment of type 2 diabetes: challenges, hopes, and anticipated successes. The Lancet Diabetes & Endocrinology, 9(8), 525–544. https://doi.org/10.1016/s2213-8587(21)00113-3
Oyenihi, O. R., Oyenihi, A. B., Adeyanju, A. A., & Oguntibeju, O. O. (2016). Antidiabetic effects of resveratrol: The way forward in its clinical utility. Journal of Diabetes Research, 2016, 1–14. https://doi.org/10.1155/2016/9737483
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.
Ruze, R., Liu, T., Zou, X., Song, J., Chen, Y., Xu, R., Yin, X., & Xu, Q. (2023). Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Frontiers in Endocrinology, 14, 1-5. https://doi.org/10.3389/fendo.2023.1161521
Sérée, E., Burcelin, R., & Savouret, J. (2009). Le resvératrol en complément thérapeutique : une piste pour la prévention du diabète de type 2 ?. Médecine Des Maladies Métaboliques, 3(5), 486–490. https://doi.org/10.1016/s1957-2557(09)73295-x
Seyyedebrahimi, S., Khodabandehloo, H., Esfahani, E. N., & Meshkani, R. (2018). The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Acta Diabetologica, 55(4), 341–353. https://doi.org/10.1007/s00592-017-1098-3
Shaito, A., Posadino, A. M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W. M., Eid, A. H., Nasrallah, G. K., & Pintus, G. (2020). Potential adverse effects of resveratrol: a literature review. International Journal of Molecular Sciences, 21(6), 2084. https://doi.org/10.3390/ijms21062084
Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of business research, 104, 333-339
Syeda, U. A., Battillo, D., Visaria, A., & Malin, S. K. (2023). The importance of exercise for glycemic control in type 2 diabetes. American Journal of Medicine Open, 9, 100031. https://doi.org/10.1016/j.ajmo.2023.100031
Termannsen, A., Sondergaard, C. S., Faerch, K., Andersen, T. H., Raben, A., & Quist, J. S. (2024). Effects of Plant-Based Diets on Markers of Insulin sensitivity: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Nutrients, 16(13), 2110. https://doi.org/10.3390/nu16132110
Thazhath, S. S., Wu, T., Bound, M. J., Checklin, H. L., Standfield, S., Jones, K. L., Horowitz, M., & Rayner, C. K. (2015). Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial. American Journal of Clinical Nutrition, 103(1), 66–70. https://doi.org/10.3945/ajcn.115.117440
Tian, B., & Liu, J. (2019). Resveratrol: a review of plant sources, synthesis, stability, modification and food application. Journal of the Science of Food and Agriculture, 100(4), 1392–1404. https://doi.org/10.1002/jsfa.10152
Timmers, S., De Ligt, M., Phielix, E., Van De Weijer, T., Hansen, J., Moonen-Kornips, E., Schaart, G., Kunz, I., Hesselink, M. K., Schrauwen-Hinderling, V. B., & Schrauwen, P. (2016). Resveratrol as Add-on therapy in Subjects with Well-COntrolled Type 2 Diabetes: A Randomized Controlled trial. Diabetes Care, 39(12), 2211–2217. https://doi.org/10.2337/dc16-0499
Tsukamoto‐Kawashima, S., Ikeda, K., Sone, M., Ogura, M., Okamura, E., Kondo, A., Ueba, Y., & Inagaki, N. (2024). An exploratory study of factors in disordered eating behavior in diabetes self‐management in Japan. Journal of Diabetes Investigation, 15(7), 874–881. https://doi.org/10.1111/jdi.14176
Villar, M. M., González-Ortiz, M., Martínez-Abundis, E., Pérez-Rubio, K. G., & Lizárraga-Valdez, R. (2014). Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metabolic Syndrome and Related Disorders, 12(10), 497–501. https://doi.org/10.1089/met.2014.0082
Yan, Y., Wu, T., Zhang, M., Li, C., Liu, Q., & Li, F. (2022). Prevalence, awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population. BMC Public Health, 22(1). https://doi.org/10.1186/s12889-022-13759-9
Zare Javid, A., Hormoznejad, R., Yousefimanesh, H. allah, Zakerkish, M., Haghighi-zadeh, M. H., Dehghan, P., & Ravanbakhsh, M. (2016). The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis. Phytotherapy Research, 31(1), 108–114. https://doi.org/10.1002/ptr.5737
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Tharles da Silva Rodrigues; Simone Gonçalves de Almeida
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
